You searched for "research"

2132 results found

Use of amniotic membrane in second stage Hughes tarsocunjunctival reconstruction

This is a retrospective, non-comparative interventional case series of 30 patients who underwent amniotic membrane transplantation to lower lid margin as part of Hughes lid reconstruction to prevent a hyperaemic, hypertrophic conjunctival margin with excessive discharge. Patients undergoing more than...

Do bilateral same day intravitreal injections increase the risk of endophthalmitis?

This large retrospective cohort study reviewed all patients who had bilateral intravitreal anti-vascular endothelial growth factor (VEGF) injections between April 2012 and August 2017. There were 101,932 procedures performed in 5890 patients. The two most common indications for injections were...

RNIB and British Blind Sport join forces to tackle the disparity of physical activity amongst blind and partially sighted people

The UK’s leading sight loss charity, Royal National Institute of Blind People (RNIB) and British Blind Sport have joined forces to launch the See Sport Differently campaign, which aims to promote accessible sports and breakdown barriers faced by blind and partially sighted people who want to get active.

Leading North London eye clinic appoints retina expert to treat growing ‘epidemic’ of patients living with myopia

Leading independent eye hospital based in Finchley, My-iClinic, has welcomed Consultant Ophthalmologist, Ms Yvonne Luo, to its growing team of specialists.

Optegra launches new fellowship programme

Leading eye health care group, Optegra, is proud to announce the appointment of its first Fellow, Mr Fadi Alfaqawi, as it unveils its Cataract and Refractive Surgery Fellowship Programme.

Hoya Vision Care announces winner of its first-ever international MiYOSMART Case Study Contest

The International MiYOSMART Case Study Contest was held at the 60th International Myopia Conference (IMC) 2024 meeting in Sanya, China, HOYA Vision Care launched its first-ever MiYOSMART Case Study Contest at the prestigious IMC meeting in Sanya, China, which plays...

Minister visits London special school to see SeeAbility eyecare team in action

Last month, disability charity SeeAbility had a special visitor to a very special school: Minister for Care, Stephen Kinnock MP. Stephen visited The Village School in London to see children receiving eye care from SeeAbility’s specialist team. He also got...

Major survey calls for new ideas on how to reinvent post diagnostic support for blind and partially sighted people

The Royal National Institute of Blind People (RNIB) is launching a new research study to better understand post-diagnostic support across the sight loss sector. People who have experienced being diagnosed with a sight condition know it’s not always easy to...

Friends of Moorfields shortlisted for the Charity Awards 2025

We are delighted to announce that we have made the shortlist for this year’s Charity Awards, the longest-running awards scheme in the charity sector. Friends of Moorfields has been shortlisted in the Healthcare and Medical Research category for our handholding...

Treatment for cause of sudden sight loss now available through the NHS in England

The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

NICE approves treatment for cause of sudden sight loss

The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

The results of the last survey Jun23

*Please be aware that this data does not form part of a peer reviewed research study. The information therein should not be relied upon for clinical purposes but instead used as a guide for clinical practice and reflection. I continue...